Загрузка...
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
Angiogenesis is essential for cancer growth and metastasis. Vascular endothelial growth factor (VEGF) is a key modulator of angiogenesis. In addition, overexpression of VEGF is correlated with advanced disease and poor prognosis. Bevacizumab, a recombinant humanized anti-VEGF monoclonal antibody, is...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2747341/ https://ncbi.nlm.nih.gov/pubmed/19774210 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|